The neuropsychiatry of multiple sclerosis (Q35752725)

10 August 2017

1 reference

title

The neuropsychiatry of multiple sclerosis (English)

1 reference

10 August 2017

0 references

1 reference

Anthony Feinstein

1

1 reference

PubMed ID

15101497

10 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Canadian Journal of Psychiatry

10 August 2017

1 reference

10 August 2017

49

1 reference

10 August 2017

3

1 reference

10 August 2017

157-163

1 reference

Affective disorders in multiple sclerosis. Review and recommendations for clinical research

10 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

An examination of suicidal intent in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Disease activity and emotional state in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis. An epidemiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Cerebral magnetic resonance imaging findings in multiple sclerosis. Relation to disturbance of affect, drive, and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Involvement of the limbic system in multiple sclerosis patients with depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Interferon beta1a and depression in secondary progressive MS: data from the SPECTRIMS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Association between bipolar affective disorder and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Disorders of laughter due to brain lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Pathological laughter and crying: a link to the cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Antidepressant pharmacotherapy of depression associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Treatment of pathologic laughing and weeping with amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Fluoxetine improves emotional incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Pathologic laughing and crying treated with levodopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

The prevalence of cognitive impairment in a community survey of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Neuropsychology of multiple sclerosis: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Anterograde and Retrograde Amnesia in Patients With Chronic Progressive Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Deficient learning and memory in early and middle phases of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Neuropsychological aspects of multiple sclerosis: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Metamemory in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Automatic memory processes in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Slowed information processing in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Automatic and controlled information processing in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Frontal-subcortical circuits and human behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Cerebral disconnection in multiple sclerosis. Relationship to atrophy of the corpus callosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Acute optic neuritis. A cognitive and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Resolution of left hemisphere cognitive dysfunction in multiple sclerosis with magnetic resonance correlates: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Neuropsychologic status in multiple sclerosis after treatment with glatiramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404900302

10.1177/070674370404900302

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15101497